1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > PharmaPoint: Migraine - Current and Future Players

PharmaPoint: Migraine - Current and Future Players

  • March 2014
  • -
  • Global Data
  • -
  • 54 pages

PharmaPoint: Migraine - Current and Future Players

Summary

GlobalData has released its pharma report, “PharmaPoint: Migraine - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Migraine Market. The report identifies and analyses the key companies shaping and driving the global Migraine market. The report provides insight into the competitive Migraine landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

- Investigation of current and future market competition for Migraine
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Migraine sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving Migraine market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Migraine market landscape? Identify, understand and capitalize

Table Of Contents

PharmaPoint: Migraine - Current and Future Players
1 Table of Contents

2 Introduction 11
2.1 Catalyst 11
2.2 Related Reports 12
2.3 Upcoming Related Reports 13
3 Market Outlook 14
3.1 Global Markets 14
3.1.1 Forecast 14
3.1.2 Drivers and Barriers - Global Issues 18
4 Current and Future Players 19
4.1 Overview 19
4.2 Trends in Corporate Strategy 22
4.3 Company Profiles 23
4.3.1 GlaxoSmithKline 23
4.3.2 AstraZeneca 26
4.3.3 Merck 28
4.3.4 Vernalis 30
4.3.5 Almirall 31
4.3.6 Pfizer 32
4.3.7 Zogenix 33
4.3.8 NuPathe 34
4.3.9 Allergan 36
4.3.10 RedHill Biopharma 37
4.3.11 OptiNose 38
4.3.12 CoLucid Pharmaceuticals 40
4.3.13 SUDA 41
4.3.14 Revance Therapeutics 42
4.3.15 NeurAxon 43
5 Appendix 45
5.1 Bibliography 45
5.2 Abbreviations 46
5.3 Methodology 47
5.4 Forecasting Methodology 47
5.4.1 Diagnosed Migraine Patients 47
5.4.2 Percent Drug-treated Patients 47
5.4.3 General Pricing Assumptions 48
5.4.4 Generic Erosion 49
5.5 Physicians and Specialists Included in this Study 49
5.6 Survey of Prescribing Physicians 50
5.7 About the Authors 51
5.7.1 Author 51
5.7.2 Reviewer 51
5.7.3 Global Head of Healthcare 52
5.8 About GlobalData 53
5.9 Disclaimer 53

1.1 List of Tables

Table 1: Global Sales Forecasts ($m) for Migraine, 2012-2023 15
Table 2: Migraine Market - Drivers and Barriers, 2012-2023 18
Table 3: Key Companies in the Migraine Market, 2013 21
Table 4: GSK's Migraine Portfolio Assessment, 2013 25
Table 5: GSK SWOT Analysis, 2013 26
Table 6: AstraZeneca's Migraine Portfolio Assessment, 2013 27
Table 7: AstraZeneca SWOT Analysis, 2013 27
Table 8: Merck's Migraine Portfolio Assessment, 2013 29
Table 9: Merck SWOT Analysis, 2013 29
Table 10: Vernalis' Migraine Portfolio Assessment, 2013 30
Table 11: Vernalis SWOT Analysis, 2013 30
Table 12: Almirall's Migraine Portfolio Assessment, 2013 31
Table 13: Almirall SWOT Analysis, 2013 31
Table 14: Pfizer's Migraine Portfolio Assessment, 2013 32
Table 15: Pfizer SWOT Analysis, 2013 33
Table 16: Zogenix's Migraine Portfolio Assessment, 2013 34
Table 17: Zogenix SWOT Analysis, 2013 34
Table 18: NuPathe's Migraine Portfolio Assessment, 2013 35
Table 19: NuPathe SWOT Analysis, 2013 35
Table 20: Allergan's Migraine Portfolio Assessment, 2013 37
Table 21: Allergan SWOT Analysis, 2013 37
Table 22: RedHill's Migraine Portfolio Assessment, 2013 38
Table 23: RedHill SWOT Analysis, 2013 38
Table 24: OptiNose's Migraine Portfolio Assessment, 2013 39
Table 25: OptiNose SWOT Analysis, 2013 39
Table 26: CoLucid Pharmaceuticals' Migraine Portfolio Assessment, 2013 40
Table 27: CoLucid Pharmaceuticals SWOT Analysis, 2013 41
Table 28: SUDA's Migraine Portfolio Assessment, 2013 42
Table 29: SUDA SWOT Analysis, 2013 42
Table 30: Revance Therapeutics' Migraine Portfolio Assessment, 2013 43
Table 31: Revance Therapeutics SWOT Analysis, 2013 43
Table 32: NeurAxon's Migraine Portfolio Assessment, 2013 44
Table 33: NeurAxon SWOT Analysis, 2013 44
Table 34: Physicians Surveyed, By Country 50

1.2 List of Figures

Figure 1: Global Sales for Migraine by Region, 2012-2023 17
Figure 2: Company Portfolio Gap Analysis in Migraine, 2012-2023 22

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Migraine  - Market Insights, Epidemiology and Market Forecast-2023

Migraine  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Migraine - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...

Global and Chinese Pain Relieving Drug Industry, 2016 Market Research Report

Global and Chinese Pain Relieving Drug Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Pain Relieving Drug Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Pain Relieving Drug industry with a focus ...

Global Antipyrine Market Research Report 2016

Global Antipyrine Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Antipyrine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Antipyrine industry, focusing on the main regions (North America, ...


Download Unlimited Documents from Trusted Public Sources

Pain Relief Industry in the US

  • November 2016
    31 pages
  • Pain Relief  

    Stroke  

  • United States  

View report >

OTC Industry in the US

  • November 2016
    52 pages
  • United States  

View report >

OTC Markets in the US

  • October 2016
    6 pages
  • OTC  

  • United States  

View report >

Otc Markets In The Us

2 months ago

Global Otc Industry

2 months ago

Otc Industry In The Us

2 months ago

Related Market Segments :

Pain Relief

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.